FP

Flagship Pioneering Portfolio holdings

AUM $268M
This Quarter Return
-28.7%
1 Year Return
-54.4%
3 Year Return
-51.2%
5 Year Return
+66.7%
10 Year Return
–
AUM
$6.47B
AUM Growth
+$6.47B
Cap. Flow
-$4.92M
Cap. Flow %
-0.08%
Top 10 Hldgs %
99%
Holding
13
New
–
Increased
–
Reduced
1
Closed
–

Top Buys

No buys this quarter

Top Sells

1
DNLI icon
Denali Therapeutics
DNLI
$4.92M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
MRNA icon
1
Moderna
MRNA
$9.37B
$4.47B 69.04%
17,581,016
– –
SANA icon
2
Sana Biotechnology
SANA
$777M
$530M 8.19%
34,239,018
– –
RUBY
3
DELISTED
Rubius Therapeutics, Inc
RUBY
$373M 5.76%
38,506,526
– –
OMGA
4
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
$293M 4.54%
25,902,269
– –
FHTX icon
5
Foghorn Therapeutics
FHTX
$286M
$290M 4.48%
12,674,120
– –
EVLO
6
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$140M 2.16%
23,030,069
– –
MCRB icon
7
Seres Therapeutics
MCRB
$166M
$120M 1.85%
14,378,802
– –
DNLI icon
8
Denali Therapeutics
DNLI
$2.23B
$117M 1.81%
2,619,968
-110,295
-4% -$4.92M
KLDO
9
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
$46.8M 0.72%
19,575,710
– –
CDAK
10
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$29M 0.45%
2,607,303
– –
SGTX
11
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
$28.6M 0.44%
10,370,369
– –
AXLA
12
DELISTED
Axcella Health Inc. Common Stock
AXLA
$26.2M 0.41%
12,548,414
– –
SYRS
13
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$9.58M 0.15%
2,938,494
– –